• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腺五肽类似物生物活性的结构要求

Structural requirements for the biological activity of thymopentin analogs.

作者信息

Heavner G A, Audhya T, Kroon D, Goldstein G

出版信息

Arch Biochem Biophys. 1985 Oct;242(1):248-55. doi: 10.1016/0003-9861(85)90499-0.

DOI:10.1016/0003-9861(85)90499-0
PMID:2996431
Abstract

Thymopentin, the synthetic pentapeptide Arg-Lys-Asp-Val-Tyr, corresponds to residues 32-36 of the thymic hormone thymopoietin. Thymopentin, like thymopoietin, induces intracellular cGMP elevations in the human T-cell line, CEM. Thymopentin also displaces radiolabeled thymopoietin from a receptor glycoprotein prepared from CEM cells, provided that a nonapeptide corresponding to thymopoietin is added to block thymopoietin binding to an additional binding site. Twenty nine analogs with single position substitutions were synthesized by solid-phase or classical solution synthesis, and are evaluated in these assays. All analogs that were active gave positive effects in both assays. A number of substitutions were tolerated at positions 2, 4, and 5, but there was an absolute requirement for L- or D-Arg at position 1 and L- or D-Asp at position 3 to maintain biological activity.

摘要

胸腺五肽,即合成的五肽精氨酸-赖氨酸-天冬氨酸-缬氨酸-酪氨酸,相当于胸腺激素促胸腺生成素的32 - 36位氨基酸残基。与促胸腺生成素一样,胸腺五肽可诱导人T细胞系CEM细胞内的环鸟苷酸(cGMP)升高。胸腺五肽还能从CEM细胞制备的受体糖蛋白上取代放射性标记的促胸腺生成素,前提是添加一种与促胸腺生成素对应的九肽来阻断促胸腺生成素与另一个结合位点的结合。通过固相或经典溶液合成法合成了29种单一位点取代的类似物,并在这些试验中进行了评估。所有具有活性的类似物在两种试验中均产生了积极效果。2、4和5位可耐受多种取代,但1位的L-或D-精氨酸以及3位的L-或D-天冬氨酸对于维持生物活性是绝对必需的。

相似文献

1
Structural requirements for the biological activity of thymopentin analogs.胸腺五肽类似物生物活性的结构要求
Arch Biochem Biophys. 1985 Oct;242(1):248-55. doi: 10.1016/0003-9861(85)90499-0.
2
Biologically active analogs of thymopentin with enhanced enzymatic stability.具有增强酶稳定性的胸腺五肽生物活性类似物。
Peptides. 1986 Nov-Dec;7(6):1015-9. doi: 10.1016/0196-9781(86)90131-2.
3
Thymopoietin to thymopentin: experimental studies.胸腺生成素与胸腺五肽:实验研究
Surv Immunol Res. 1985;4 Suppl 1:1-10. doi: 10.1007/BF02919050.
4
Cooperativity of thymopoietin 32-36 (the active site) and thymopoietin 38-45 in receptor binding.
Regul Pept. 1984 Oct;9(3):155-64. doi: 10.1016/0167-0115(84)90068-5.
5
Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor.精氨酸-赖氨酸-天冬氨酸-缬氨酸-酪氨酸(胸腺五肽)可加速胆碱能诱导的重组烟碱型受体失活(脱敏)。
Cell Mol Neurobiol. 1988 Sep;8(3):325-31. doi: 10.1007/BF00711174.
6
Peptide analogs of thymopentin distinguish distinct thymopoietin receptor specificities on two human T cell lines.
Regul Pept. 1990 Feb 4;27(2):257-62. doi: 10.1016/0167-0115(90)90044-w.
7
Selected human T cell lines respond to thymopoietin with intracellular cyclic GMP elevations.
Immunopharmacology. 1988 Sep-Oct;16(2):115-22. doi: 10.1016/0162-3109(88)90020-3.
8
Syntheses and effects of a thymopoietin II fragment and its analogs on the impaired T-cell transformation in a patient with common variable immunodeficiency.
J Appl Biochem. 1985 Dec;7(6):408-22.
9
The effect of TP-5 and its analogs on skin grafts in mice.TP-5及其类似物对小鼠皮肤移植的影响。
J Immunopharmacol. 1985;7(1):67-78.
10
Induction and augmentation of mitogen-induced immune interferon production in human lymphocytes by a synthetic thymopoietin pentapeptide.
Biomed Biochim Acta. 1984;43(6):K9-12.

引用本文的文献

1
Molecular analysis of thymopentin binding to HLA-DR molecules.胸腺五肽与HLA - DR分子结合的分子分析
PLoS One. 2007 Dec 26;2(12):e1348. doi: 10.1371/journal.pone.0001348.
2
Nasal epithelial permeation of thymotrinan (TP3) versus thymocartin (TP4): competitive metabolism and self-enhancement.胸腺三肽(TP3)与胸腺卡汀(TP4)的鼻上皮渗透:竞争性代谢与自我增强
Pharm Res. 2000 Feb;17(2):222-8. doi: 10.1023/a:1007529716926.
3
Thymopentin and splenopentin as immunomodulators. Current status.胸腺五肽和脾氨肽作为免疫调节剂。现状。
Immunol Res. 1998;17(3):345-68. doi: 10.1007/BF02786456.
4
Immunomodulation with thymopentin: in vitro studies.
Med Oncol Tumor Pharmacother. 1989;6(1):19-23. doi: 10.1007/BF02985219.